Home › Zacks Investment Research Upgrades Immunomedics, Inc. (IMMU) to Buy
 

Keywords :   


Zacks Investment Research Upgrades Immunomedics, Inc. (IMMU) to Buy

2016-04-11 03:27:16| Biotech - Topix.net

The firm currently has a $3.00 price target on the biopharmaceutical company's stock. Zacks Investment Research 's price target points to a potential upside of 12.78% from the company's previous close.

Tags: buy research investment upgrades

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
More »